114 filings
8-K
CARA
Cara Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
CARA
Cara Therapeutics Inc
4 Mar 24
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
4:10pm
8-K
CARA
Cara Therapeutics Inc
2 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
CARA
Cara Therapeutics Inc
22 Jan 24
Cost Associated with Exit or Disposal Activities
4:19pm
8-K
CARA
Cara Therapeutics Inc
18 Dec 23
Regulation FD Disclosure
7:10am
8-K
kgdf1meser43qo
13 Nov 23
Corporate Presentation November 2023
4:28pm
8-K
am74htne
13 Nov 23
Cara Therapeutics Reports Third Quarter 2023 Financial Results
4:11pm
8-K
s8vnua
2 Nov 23
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
7:10am
8-K
bg4sek 7wwvul
7 Aug 23
Corporate Presentation August 2023
4:24pm
8-K
bguazp
7 Aug 23
Cara Therapeutics Reports Second Quarter 2023 Financial Results
4:10pm
8-K
el6nfpc4rih0tkx1lz
3 Aug 23
Cara Therapeutics Appoints Helen M. Boudreau to
7:06am
8-K
5w5140nx owc8
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
rtr5rwwwfy9
15 May 23
Corporate Presentation May 2023
4:21pm
8-K
mg4duya6586fwnsyv
15 May 23
Cara Therapeutics Reports First Quarter 2023 Financial Results
4:10pm
8-K
2dxh7lo nzo7jm
23 Mar 23
Corporate Presentation March 2023
5:04pm
8-K
xumdobpjgh2u6mv
10 Mar 23
Regulation FD Disclosure
5:03pm
8-K
078urrnauab2ew2nvudl
6 Mar 23
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
cxhspkhsdr11k5j
9 Jan 23
Regulation FD Disclosure
7:00am
8-K
iwflky
7 Nov 22
Regulation FD Disclosure
4:47pm
8-K
0s15l3
7 Nov 22
Cara Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm